Switch to:
More From Other Websites
NYSE stocks posting largest percentage decreases Sep 19 2014
NYSE stocks posting largest percentage decreases Sep 19 2014
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA Sep 19 2014
ImmunoCellular Therapeutics (IMUC) Jumps: Stock Up 9% Sep 18 2014
Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% Sep 18 2014
Alder Biopharmaceuticals (ALDR) in Focus: Stock Up 5.2% Sep 18 2014
Five Prime Therapeutics' Novel Target Licensed by Glaxo Sep 17 2014
Regeneron Gets Breakthrough Therapy Status for Eylea Sep 17 2014
Dendreon (DNDN) in Focus: Stock Up 9.4% Sep 16 2014
Eli Lilly's Cyramza Scores in Colorectal Cancer Study Sep 15 2014
Genomic Health Reveals Positive Oncotype DX Test Results Sep 15 2014
Cytokinetics (CYTK) Looks Strong: Stock Gains 17.2% Sep 11 2014
Xenoport/NIAAA Collaborate on Alcoholism Therapy Sep 10 2014
ZIOPHARM Oncology (ZIOP) in Focus: Stock Rises 10.4% Sep 08 2014
BioDelivery Sciences (BDSI) Jumps: Stock Rises 8.9% Sep 08 2014
Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint Sep 05 2014
Halozyme's PEGPH20 Program Gains Fast Track Designation Sep 05 2014
XOMA Corporation (XOMA) Jumps: Stock Rises 6.2% Sep 05 2014
Amgen Seeks EU Approval for PCSK9 Inhibitor Evolocumab Sep 04 2014
Cambrex To Present At Rodman & Renshaw 16th Annual Global Investment Conference Sep 03 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK